Latest News
Mark Zuckerberg Overtakes Michael Dell As 5th Richest Amid Dell Selloff
200%. That's how much Dell shares have swelled by this year as they more than tripled in value, despite a recent selloff. Michael Dell's fortune opened 2026 at $141 billion, ranking him as the 13th-ri
Zillow Group Securities Fraud Class Action Arising from Alleged Anticompetitive Agreement and Related Regulatory Risks - Investors May Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC
New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 20, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind inv
Pentair ALERT: Securities Fraud Investigation by Block & Leviton Could Allow PNR Investors to Recover Losses
Boston, Massachusetts--(Newsfile Corp. - July 20, 2026) - Block & Leviton is investigating Pentair (NYSE: PNR) for potential securities law violations. Investors who have lost money in their Pentair i
Hub Group, Inc. Securities Fraud Class Action Result of Erroneous Financial Statements and approximately 31% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 20, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind inv
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 20, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind inv
Via Transportation, Inc. Securities Class Action Result of Undisclosed Growth Obstacles and Approximately 70% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 20, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind inv
McDonald's: Consistency Deserves A Better Multiple (Rating Upgrade)
McDonald's has underperformed the market, declining 10% versus a 14% benchmark rally since my last coverage. Recent catalysts and compressed earnings multiples now make MCD attractive, prompting my ra
Cosmos Health Expands Pharma Cell Partnership in Albania with Annualized Orders Projected to Exceed 54,000 Units
Cosmos Health expands its Sky Premium Life partnership with Pharma Cell in Albania, with average monthly orders already exceeding 4,500 units, and projected to exceed 54,000 annually Products are dist
Futu Holdings Limited Securities Fraud Class Action Result of Undisclosed Regulatory Compliance Failures and approximately 32% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 20, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind inv
PicS N.V. Notice of August 4, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 20, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies i
Ball Q2 Preview: Not An Appealing Investment Yet
Ball Corporation remains a hold as I await clear signs of profitability improvement or operational momentum post-earnings. Q2 expectations are for $0.99 adjusted EPS, $0.88 GAAP EPS, and $3.68B revenu
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of LXP Industrial Trust (NYSE: LXP)
NEW YORK, July 20, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is
Scribe Therapeutics Starts IPO Effort For CRISPR Pipeline Development
Scribe Therapeutics is a Phase 1 clinical-stage biopharma developing in vivo CRISPR gene editing for disease prevention, targeting atherosclerotic cardiovascular disease. SCTX's lead candidate, STX-11
Apple set to beat Q3 estimates as BofA sees margin dip as transitory
Apple Inc (NASDAQ:AAPL, XETRA:APC) is expected to beat consensus estimates for its fiscal third quarter, according to Bank of America, even as the bank takes a more conservative view of iPhone seasona
Inside LOEV: Harding Loevner's First Active ETF
On Monday, July 20, 2026, Harding Loevner announced the debut of the Harding Loevner International Developed Markets Select Equity ETF (LOEV). LOEV marks a significant milestone for the firm, as it's
Beyond the Spot Price: The Changing Landscape of Commodity ETFs
Historically investors have bought physical commodity ETFs to gain direct exposure to the spot price of real assets. These funds provide a straightforward way to hedge against inflation and market vol
Fifth Third Bancorp: Comerica Is Now A Growth Catalyst
Fifth Third Bancorp (FITB) is upgraded to 'Buy' following the successful Comerica acquisition and robust Q2'26 earnings beat. FITB's net interest income surged 48% year-over-year, driven by Comerica i
JEPQ: There's A New Kid In Town
Goldman Sachs Nasdaq-100 Premium Income ETF (GPIQ) is rated Buy, while JPMorgan Nasdaq Equity Premium Income ETF (JEPQ) is rated Hold. GPIQ has outperformed JEPQ in recent months, driven by its use of
Iconic candymaker to lay off hundreds, move US headquarters out of New Jersey
Mars Wrigley filed a WARN notice to cut 307 jobs at its Newark headquarters, ending its presence in the New Jersey city as it shifts to Chicago.
Zuckerberg Is Quietly Turning Meta Into A Compute Provider Ahead Of Q2 Earnings
Meta Platforms, Inc.'s Q2 earnings will focus on CapEx guidance (already revised for 2026); market sentiment hinges on Meta's ability to monetize AI infrastructure investments. Meta's recent pivot tow